Breaking News

RBS First-Half Profit Doubles, Shares Gain as Much as 10% in London
Tweet TWEET

Temasek Buys Shares of Gilead Sciences, China’s 21Vianet

Temasek Holdings Pte, Singapore’s state-owned investment firm, added shares of pharmaceutical maker Gilead Sciences Inc. (GILD) and Chinese Web data company 21Vianet Group Inc. (VNET) in the fourth quarter.

Temasek, directly or through its units, bought 5.65 million shares of Foster City, California-based Gilead valued at $424 million as of Dec. 31 and 6.67 million American depositary receipts of Beijing-based 21Vianet worth $157 million, according to a filing today with the U.S. Securities and Exchange Commission.

Temasek, wholly owned by Singapore’s Ministry of Finance, is the ninth-biggest state investment company, according to the Sovereign Wealth Fund Institute website. The world’s biggest is Norway’s Government Pension Fund Global, while Singapore’s state fund GIC Pte is the eighth-biggest, according to the institute estimates.

The share of assets denominated in U.S. dollars in Temasek’s portfolio declined to 6 percent as of March 31 from 7 percent in the previous year, according to the investment firm’s latest annual review published in July.

Money managers who oversee more than $100 million in equities must file a Form 13F with the SEC within 45 days of each quarter’s end to show their U.S.-listed stocks, options and convertible bonds. The filings don’t show non-U.S. securities or how much cash the firms hold.

To contact the reporters on this story: Klaus Wille in Singapore at kwille@bloomberg.net; Devin Banerjee in New York at dbanerjee2@bloomberg.net

To contact the editors responsible for this story: Andreea Papuc at apapuc1@bloomberg.net; Christian Baumgaertel at cbaumgaertel@bloomberg.net

Bloomberg reserves the right to remove comments but is under no obligation to do so, or to explain individual moderation decisions.

Please enable JavaScript to view the comments powered by Disqus.